Navigation Links
More Doubt on Link Between a Blood Chemical and Heart Disease
Date:2/21/2012

TUESDAY, Feb. 21 (HealthDay News) -- Having high levels of the amino acid homocysteine won't raise your risk of developing heart disease, a new analysis indicates.

The findings appear to close the door on the potential benefit of lowering homocysteine levels with folic acid supplements, according to report author Robert Clarke, of the University of Oxford in the United Kingdom, and his colleagues.

The researchers also said previous studies that suggested high levels of homocysteine might be a modifiable risk factor for heart disease were plagued by publication bias and methodological problems.

Clarke and his team analyzed data on nearly 50,000 heart disease patients and 68,000 healthy people, culled from 86 published studies and 19 unpublished studies. There was no increased risk of heart disease in people who had an MTHFR gene variant that is associated with 20 percent higher blood homocysteine levels.

The MTHFR gene plays a role in the production of methylene tetrahydrofolate reductase, which uses folate to break down and remove homocysteine.

The study appears in this week's issue of the journal PLoS Medicine.

"The discrepancy between the overall results in the unpublished and the published datasets is too extreme to be plausibly dismissed as a chance finding," the researchers wrote. "Some studies, particularly if small, might have been prioritized for publication by investigators, referees or editors according to the positivity of their results and some may have been liable to other methodological problems that bias the average of all results. To avoid such biases, we chiefly emphasize the new results from the previously unpublished datasets."

"The magnitude of the effect of publication bias is substantial and, in addition to distorting the association of MTHFR with [coronary heart disease] in published studies, publication bias may also help explain the discrepant findings recently reported for MTHFR and stroke," they concluded.

More information

The U.S. National Heart Lung and Blood Institute has more about coronary heart disease.

-- Robert Preidt

SOURCE: PLoS Medicine, news release, Feb. 21, 2012


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Doubt Cast on Use of Genetic Test Before Plavix
2. Requests for Alzheimers disease research grants up by 33 percent, as federal funding in doubt
3. Study Casts Doubt on Hot Dogs Link to Colon Cancer
4. New Report Casts More Doubt on Virus Link to Chronic Fatigue Syndrome
5. Intensive care nurses have doubts about method for establishing brain death
6. Lifesaving antibiotics face doubtful future
7. Study Casts Doubt on Hospice Admission Criteria for Patients With Dementia
8. The balancing act between protection and inflammation in MS
9. UCLA scientists report link between traumatic brain injury, post-traumatic stress disorder
10. Molecular profiling reveals differences between primary and recurrent ovarian cancers
11. ROCK off: Study establishes molecular link between genetic defect and heart malformation
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
More Doubt on Link Between a Blood Chemical and Heart Disease
(Date:5/26/2016)... , ... May 26, 2016 , ... ... clinical outcomes, hosted members and suppliers for its inaugural Member Conference at the ... their mission of elevating the operational health of America’s healthcare providers. , The ...
(Date:5/26/2016)... ... May 26, 2016 , ... Connor Sports, through ... a partner for the Tamika Catchings Legacy Tour that will commemorate the ... in hardwood basketball surfaces in all forms and levels of the game, Connor Sports ...
(Date:5/26/2016)... ... ... The Woodlands at John Knox Village , Florida’s first Life Plan ... and healing, celebrated its grand opening, today. The Woodlands at John Knox Village is ... Staff. , “This is an incredibly fulfilling time for John Knox Village as we ...
(Date:5/26/2016)... ... ... There are nearly 14.5 million people living with and beyond cancer in the ... 2016, communities around the world will gather to recognize these cancer survivors as part ... is an annual worldwide Celebration of Life that is held on the first Sunday ...
(Date:5/26/2016)... ... 2016 , ... Catalent Pharma Solutions, the leading global provider ... global clinical supply services, today announced two key appointments and the opening of ... strategic growth plans in the Asia Pacific region. , Howard Kim has joined ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... -- FDA 510(k) clearance covers Confocal ... urological and surgical applications Mauna Kea ... the multidisciplinary confocal laser endomicroscopy (CLE) platform, today ... with the 12 th 510(k) clearance from ... new FDA clearance covers Confocal Miniprobes indicated for ...
(Date:5/25/2016)... , May 25, 2016  According to Kalorama Information, ... billion in 2015.  Though these are challenging times ... opportunity for success for companies that remain optimistic ... of new growth prospects medical device companies spend ... and development (R&D) than do companies in other ...
(Date:5/25/2016)... PARIS , May 25, 2016 ... system disorders, announces that an oral presentation entitled "High doses ... the MS-SPI trial" will be given by Professor Ayman ... the 2nd Congress of the European Academy of Neurology (EAN) ... "MS and related disorders 3" will take place on Sunday, ...
Breaking Medicine Technology: